We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 139 → 0 (-139)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $835M → $0 (-$835M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 137

Holders
–
Holders Change
-139
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
137
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$180M
2
BlackRock
BlackRock
New York
-$72.5M
3
BBA
Baker Bros. Advisors
New York
-$37.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$37.2M
5
TAL
TIG Advisors LLC
New York
-$26.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
WMSA
51
Weiss Multi-Strategy Advisers
New York
– -$2.23M -111,524 Closed
CS
52
Credit Suisse
Switzerland
– -$2.2M -110,430 Closed
AI
53
Arena Investors
New York
– -$2.15M -107,913 Closed
CAC
54
Cowen and Company
New York
– -$5K -100,000 Closed
HM
55
Harvest Management
New York
– -$2M -100,000 Closed
VAM
56
Vazirani Asset Management
New York
– -$2M -100,000 Closed
Macquarie Group
57
Macquarie Group
Australia
– -$1.86M -93,236 Closed
IHAM
58
Integral Health Asset Management
New York
– -$3.31M -92,000 Closed
N
59
Natixis
France
– -$1.78M -89,400 Closed
CC
60
Centiva Capital
New York
– -$1.7M -85,000 Closed
Ameriprise
61
Ameriprise
Minnesota
– -$1.68M -84,424 Closed
Swiss National Bank
62
Swiss National Bank
Switzerland
– -$1.56M -78,300 Closed
Verition Fund Management
63
Verition Fund Management
Connecticut
– -$1.5M -75,260 Closed
Two Sigma Advisers
64
Two Sigma Advisers
New York
– -$1.49M -74,700 Closed
Invesco
65
Invesco
Georgia
– -$1.32M -66,396 Closed
BHMP
66
Bardin Hill Management Partners
New York
– -$1.32M -66,085 Closed
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
– -$1.3M -64,945 Closed
BFM
68
Boothbay Fund Management
New York
– -$1.26M -63,089 Closed
EPL
69
EDBI Pte Ltd
Singapore
– -$1.11M -55,855 Closed
CS
70
Candriam SCA
Luxembourg
– -$1.08M -54,112 Closed
Marshall Wace
71
Marshall Wace
United Kingdom
– -$1.01M -50,773 Closed
VF
72
Virtu Financial
New York
– -$1.01M -50,773 Closed
PI
73
Putnam Investments
Massachusetts
– -$1M -50,399 Closed
Walleye Capital
74
Walleye Capital
New York
– -$997K -49,979 Closed
BCM
75
BCK Capital Management
Connecticut
– -$878K -44,000 Closed
1 2
3
4 5

FMTX Hedge Fund Activity: Q4 2022 in Review

0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2022, worth a combined $0 — down 100% from $835M a quarter earlier.

Sellers outnumbered buyers: 137 funds closed out of FMTX and 0 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $180M sold.

  • 0 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2022, down from 139 in Q3 2022.
  • Funds reported $0 of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2022 and 137 closed out, a net change of -137 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2022 was RA Capital Management, an estimated $180M sold.

Based on aggregated 13F filings for Q4 2022.